tiprankstipranks
Trending News
More News >
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market

Grace Therapeutics (GRCE) Technical Analysis

Compare
1,172 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Grace Therapeutics’s (GRCE) Moving Averages Convergence Divergence (MACD) indicator is 0.12, suggesting Grace Therapeutics is a Sell.
Grace Therapeutics’s (GRCE) 20-Day exponential moving average is 3.48, while Grace Therapeutics’s (GRCE) share price is $3.8, making it a Buy.
Grace Therapeutics’s (GRCE) 50-Day exponential moving average is 3.33, while Grace Therapeutics’s (GRCE) share price is $3.8, making it a Buy.

Grace Therapeutics (GRCE) Pivot Points

Jan 10, 2026, 04:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.45
3.55
3.64
3.74
3.83
3.93
4.02
Fibonacci
3.55
3.62
3.67
3.74
3.81
3.86
3.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Grace Therapeutics (GRCE) Moving Averages

Jan 10, 2026, 04:02 PM
Period
Simple
Exponential
MA5
3.69Buy
3.68Buy
MA10
3.54Buy
3.59Buy
MA20
3.45Buy
3.48Buy
MA50
3.26Buy
3.33Buy
MA100
3.19Buy
3.22Buy
MA200
3.00Buy
3.09Buy
Grace Therapeutics’s (GRCE) 10-Day exponential moving average is 3.59, while Grace Therapeutics’s (GRCE) share price is $3.8, making it a Buy.
Grace Therapeutics’s (GRCE) 100-Day exponential moving average is 3.22, while Grace Therapeutics’s (GRCE) share price is $3.8, making it a Buy.
Grace Therapeutics’s (GRCE) stock price is $3.8 and Grace Therapeutics’s (GRCE) 50-day simple moving average is 3.26, creating a Buy signal.
Grace Therapeutics’s (GRCE) stock price is $3.8 and Grace Therapeutics’s (GRCE) 100-day simple moving average is 3.19, creating a Buy signal.
Grace Therapeutics’s (GRCE) stock price is $3.8 and Grace Therapeutics’s (GRCE) 200-day simple moving average is 3.00, creating a Buy signal.

Grace Therapeutics (GRCE) Technical Indicators

Jan 10, 2026, 04:02 PM
Name
Value
Implied Action
RSI (14)
74.59
Sell
STOCH (9,6)
73.52
Neutral
STOCHRSI (14)
76.51
Neutral
MACD (12,26)
0.12
Sell
ADX (14)
44.11
Neutral
Williams %R
-16.95
Sell
CCI (14)
191.57
Sell
ATR (14)
0.16
-
Ultimate Oscillator
50.04
Neutral
ROC
13.43
Buy
Grace Therapeutics’s (GRCE) Relative Strength Index (RSI) is 74.59, creating a Sell signal.
Grace Therapeutics’s (GRCE) Trend Strength Indicator (ADX) is 44.11, creating a Neutral signal.
Grace Therapeutics’s (GRCE) Commodity Channel Index (CCI) is 191.57, creating a Sell signal.
Grace Therapeutics’s (GRCE) Price Rate of Change (ROC) is 13.43, creating a Buy signal.

FAQ

Is GRCE a Buy, Hold, or Sell?
Based on GRCE’s technical indicators, GRCE is a Buy.
    What is GRCE’s RSI (14)?
    GRCE’s RSI (14) is 74.59, which suggests GRCE is a Sell.
      What is GRCE’s MACD?
      GRCE’s MACD is 0.12, which suggests GRCE is a Sell.
        What is GRCE’s 5-day moving average?
        GRCE’s 5-day moving average is 3.69, which suggests GRCE is a Buy.
          What is GRCE’s 20-day moving average?
          GRCE 20-day moving average is 3.45, which suggests GRCE is a Buy.
            What is GRCE’s 50-day moving average?
            GRCE’s 50-day moving average is 3.26, which suggests GRCE is a Buy.
              What is GRCE’s 200-day moving average?
              GRCE’s 200-day moving average is 3.00, which suggests GRCE is a Buy.
                What is GRCE’s Williams % R (14)?
                GRCE’s Williams % R (14) is -16.95, which suggests GRCE is a Sell.
                  What is GRCE’s CCI (14)?
                  GRCE’s CCI (14) is 191.57, which suggests GRCE is a Sell.